Schedule 13D ownership disclosure

RECURSION PHARMACEUTICALS INC CL A

Class A Common Stock, $0.00001 par value per share · CUSIP: 75629V104

Event date: 2024-11-20

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Mubadala Investment Co PJSCReported CIK 0001704268

    Shares: 0.00 · Class: 0.0%

  • Mamoura Diversified Global Holding PJSCReported CIK 0001419351

    Shares: 0.00 · Class: 0.0%

  • MDC Capital Partners (Ventures) GP, LP

    Shares: 7,062,869.00 · Class: 1.4%

  • MDC Capital Partners (Ventures), LPReported CIK 0001714230

    Shares: 7,062,869.00 · Class: 1.4%

  • MIC Capital Management UK LLPReported CIK 0001889830

    Shares: 2,581,164.00 · Class: 0.5%

  • MC Alternative Solutions, LPReported CIK 0001974767

    Shares: 1,388,889.00 · Class: 0.3%

  • MIC Capital Partners (Ventures) Europe Parallel (Luxembourg) Aggregator SCSp

    Shares: 1,192,275.00 · Class: 0.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001999371-25-021183
Form type
SCHEDULE 13D/A
Filer
Mubadala Investment Co PJSC
CIK
CIK 1704268
Filed
Dec 23, 2025
Reporting period
Nov 20, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub